Published in Can Urol Assoc J on June 01, 2009
Predicting Life Expectancy in Men Diagnosed with Prostate Cancer. Eur Urol (2015) 2.29
Challenging the 10-year rule: The accuracy of patient life expectancy predictions by physicians in relation to prostate cancer management. Can Urol Assoc J (2012) 1.32
Remaining Life Expectancy Measurement and PSA Screening of Older Men. J Geriatr Oncol (2012) 0.79
Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2008) 8.14
Results of conservative management of clinically localized prostate cancer. N Engl J Med (1994) 5.04
Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force. Ann Intern Med (2008) 3.73
Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists. Am J Med (1998) 2.05
Do older men benefit from curative therapy of localized prostate cancer? J Clin Oncol (2003) 1.70
Age-specific reference ranges for serum prostate-specific antigen. Urol Clin North Am (1997) 1.23
Prostate cancer in elderly men. Rev Urol (2008) 1.19
Changing patterns in competing causes of death in men with prostate cancer: a population based study. J Urol (2004) 1.18
Prostate-specific antigen screening in elderly men. J Natl Cancer Inst (2003) 1.16
Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical Gleason score and patient age. J Urol (2002) 1.10
Is a digital rectal examination necessary in the diagnosis and clinical staging of early prostate cancer? BJU Int (2005) 0.93
Perineural invasion in cancer: a review of the literature. Cancer (2009) 3.06
Perineural invasion is an independent predictor of outcome in colorectal cancer. J Clin Oncol (2009) 3.04
Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications. Clin Cancer Res (2008) 2.58
Global gene expression analysis of reactive stroma in prostate cancer. Clin Cancer Res (2009) 2.34
Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression. Cancer Res (2005) 2.14
COUP-TFII inhibits TGF-β-induced growth barrier to promote prostate tumorigenesis. Nature (2012) 2.11
SRC-3 is required for prostate cancer cell proliferation and survival. Cancer Res (2005) 2.07
Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival. Clin Cancer Res (2002) 1.89
High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy. Am J Surg Pathol (2004) 1.61
Steroid receptor coactivator-3/AIB1 promotes cell migration and invasiveness through focal adhesion turnover and matrix metalloproteinase expression. Cancer Res (2008) 1.54
Presurgical stress management improves postoperative immune function in men with prostate cancer undergoing radical prostatectomy. Psychosom Med (2011) 1.52
Intraoperative consultation for renal lesions. Implications and diagnostic pitfalls in 324 cases. Am J Clin Pathol (2003) 1.52
Pseudoglandular (adenoid, acantholytic) penile squamous cell carcinoma: a clinicopathologic and outcome study of 7 patients. Am J Surg Pathol (2009) 1.51
The expression of Sprouty1, an inhibitor of fibroblast growth factor signal transduction, is decreased in human prostate cancer. Cancer Res (2004) 1.51
The association of urinary nerve growth factor levels with bladder outlet obstruction in women. Female Pelvic Med Reconstr Surg (2015) 1.38
Relaxin promotes prostate cancer progression. Clin Cancer Res (2007) 1.34
Decreased expression and androgen regulation of the tumor suppressor gene INPP4B in prostate cancer. Cancer Res (2011) 1.32
Targeting Aurora kinases for the treatment of prostate cancer. Cancer Res (2006) 1.31
Pim-2 upregulation: biological implications associated with disease progression and perinueral invasion in prostate cancer. Prostate (2005) 1.24
Regional cerebral autoregulation during orthostatic stress: age-related differences. J Gerontol A Biol Sci Med Sci (2005) 1.23
Development of an immunoassay for serum caveolin-1: a novel biomarker for prostate cancer. Clin Cancer Res (2003) 1.22
"Chopstick" surgery: a novel technique improves surgeon performance and eliminates arm collision in robotic single-incision laparoscopic surgery. Surg Endosc (2009) 1.19
Activation of NF-{kappa}B by TMPRSS2/ERG Fusion Isoforms through Toll-Like Receptor-4. Cancer Res (2010) 1.18
Anomalies of the wolffian duct derivatives encountered at radical prostatectomy. Rev Urol (2005) 1.18
Preoperative serum caveolin-1 as a prognostic marker for recurrence in a radical prostatectomy cohort. Clin Cancer Res (2006) 1.16
Penile squamous cell carcinoma clinicopathological features, nodal metastasis and outcome in 333 cases. J Urol (2009) 1.12
Expression of neutral amino acid transporter ASCT2 in human prostate. Anticancer Res (2003) 1.09
FGFR-4 Arg³⁸⁸ enhances prostate cancer progression via extracellular signal-related kinase and serum response factor signaling. Clin Cancer Res (2011) 1.07
Developments in the pathology of penile squamous cell carcinomas. Urology (2010) 1.07
GGAP2/PIKE-a directly activates both the Akt and nuclear factor-kappaB pathways and promotes prostate cancer progression. Cancer Res (2009) 1.04
Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) in human prostate. Prostate (2004) 1.02
Renal cystic neoplasms and renal neoplasms associated with cystic renal diseases: pathogenetic and molecular links. Adv Anat Pathol (2003) 1.01
Neuroepithelial interactions in prostate cancer are enhanced in the presence ofprostatic stroma. Urology (2003) 1.00
Prior circumcision does not complicate repair of hypospadias with an intact prepuce. J Urol (2006) 0.99
Flexor carpi ulnaris tendinopathy. J Hand Surg Am (2005) 0.97
Which skills really matter? proving face, content, and construct validity for a commercial robotic simulator. Surg Endosc (2013) 0.95
Neural cell adhesion molecule is upregulated in nerves with prostate cancer invasion. Hum Pathol (2003) 0.90
Haploinsufficiency of the maspin tumor suppressor gene leads to hyperplastic lesions in prostate. Cancer Res (2008) 0.89
Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data. Int J Radiat Oncol Biol Phys (2004) 0.88
Ethnic and racial differences in prostate stromal estrogen receptor alpha. Prostate (2005) 0.88
Histologic grade and perineural invasion are more important than tumor thickness as predictor of nodal metastasis in penile squamous cell carcinoma invading 5 to 10 mm. Am J Surg Pathol (2008) 0.87
Familial aggregation of prostate cancer in African-Americans and white Americans. Prostate (2003) 0.85
The effects of a presurgical stress management intervention for men with prostate cancer undergoing radical prostatectomy. J Clin Oncol (2009) 0.84
Semaphorin 4F as a critical regulator of neuroepithelial interactions and a biomarker of aggressive prostate cancer. Clin Cancer Res (2013) 0.84
Enhanced systemic T-cell activation after in situ gene therapy with radiotherapy in prostate cancer patients. Int J Radiat Oncol Biol Phys (2004) 0.83
Combining radiotherapy with gene therapy (from the bench to the bedside): a novel treatment strategy for prostate cancer. Oncologist (2002) 0.80
Treatment of ampullary villous adenomas that may harbor carcinoma. J Gastrointest Surg (2002) 0.80
The Single-Incision Sling to Treat Female Stress Urinary Incontinence: A Dynamic Computational Study of Outcomes and Risk Factors. J Biomech Eng (2015) 0.79
Prenatal diagnosis of 24 cases of microduplication 22q11.2: an investigation of phenotype-genotype correlations. Prenat Diagn (2014) 0.79
Expanding the therapeutic index of radiation therapy by combining in situ gene therapy in the treatment of prostate cancer. Technol Cancer Res Treat (2006) 0.78
Neurovirulence and latency of drug-resistant clinical herpes simplex viruses in animal models. J Med Virol (2010) 0.78
Efficacy of trivalent inactivated influenza vaccines in the cotton rat Sigmodon hispidus model. Vaccine (2011) 0.77
Differentiated precursor lesions and low-grade variants of squamous cell carcinomas are frequent findings in foreskins of patients from a region of high penile cancer incidence. Histopathology (2011) 0.76
Distribution and characterization of subtypes of penile intraepithelial neoplasia and their association with invasive carcinomas: a pathological study of 139 lesions in 121 patients. Hum Pathol (2011) 0.76
Urethral diverticulum after midurethral sling erosion, excision, and subsequent management. Female Pelvic Med Reconstr Surg (2014) 0.76
Complex rectovaginal fistulas after pelvic organ prolapse repair with synthetic mesh: a multidisciplinary approach to evaluation and management. Female Pelvic Med Reconstr Surg (2012) 0.75
Robot-assisted laparoscopic prostatectomy performed in a patient with severe thrombocytopenia due to primary myelofibrosis. Can Urol Assoc J (2009) 0.75
Outcomes in Pelvic Organ Prolapse Surgery in Women Using Chronic Antithrombotic Therapy. Female Pelvic Med Reconstr Surg (2017) 0.75
[Remifentanil: does the infusion regimen make a difference in the prevention of hemodynamic responses to tracheal intubation?]. Rev Bras Anestesiol (2007) 0.75
Medullary Carcinoma of the Penis: A Distinctive HPV-related Neoplasm: A Report of 12 Cases. Am J Surg Pathol (2017) 0.75
The reliability of the "Scratch test". J Hand Surg Eur Vol (2008) 0.75
Vesicosalpingo Fistula: A Case Presentation And Review of The Literature. Female Pelvic Med Reconstr Surg (2016) 0.75
Procedure Choice in Primary Versus Recurrent Prolapse: A Study of Fellowship-Trained Surgeons. Female Pelvic Med Reconstr Surg (2017) 0.75